Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Center Research Lab, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
BMC Surg. 2023 Aug 5;23(1):218. doi: 10.1186/s12893-023-02125-0.
We aimed to investigate the effects of intermittent bolus paravertebral block on analgesia and recovery in open hepatectomy.
Eighty 18-70 years old, American Society of Anesthesiologists level I-III patients scheduled for hepatectomy with a J-shaped subcostal incision were enrolled and randomized to receive either intermittent bolus paravertebral ropivacaine (0.5% loading, 0.2% infusion) or 0.9% saline infusion at 1:1 ratio (25 ml loading before surgery, 0.125 ml/kg/h bolus for postoperative 48 h). The primary outcome was set as postoperative 48 h cumulative intravenous morphine consumption recorded by a patient-controlled analgesic pump.
Thirty-eight patients in each group completed the study. The cumulative morphine consumptions were lower in the paravertebral block than control group at postoperative 24 (difference -10.5 mg, 95%CI -16 mg to -6 mg, P < 0.001) and 48 (difference -12 mg, 95%CI -19.5 mg to -5 mg, P = 0.001) hours. The pain numerical rating scales at rest were lower in the paravertebral block than control group at postoperative 4 h (difference -2, 95%CI -3 to -1, P < 0.001). The active pain numerical rating scales were lower in the paravertebral block than control group at postoperative 12 h (difference -1, 95%CI -2 to 0, P = 0.005). Three months postoperatively, the paravertebral block group had lower rates of hypoesthesia (OR 0.28, 95%CI 0.11 to 0.75, P = 0.009) and numbness (OR 0.26, 95%CI 0.07 to 0.88, P = 0.024) than the control group.
Intermittent bolus paravertebral block provided an opioid-sparing effect and enhanced recovery both in hospital and after discharge in patients undergoing hepatectomy.
clinicaltrials.gov (NCT04304274), date: 11/03/2020.
我们旨在研究间断推注椎旁阻滞对开腹肝切除术患者的镇痛和恢复的影响。
纳入了 80 名年龄在 18-70 岁、ASA 分级 I-III 级、接受 J 形肋缘下切口开腹肝切除术的患者,采用随机数字表法将其分为椎旁罗哌卡因间断推注组(0.5%负荷量,0.2%持续输注)或生理盐水 1:1 混合组(手术前给予 25ml 负荷量,术后 48 小时内以 0.125ml/kg/h 推注)。主要结局为术后 48 小时内患者自控镇痛泵记录的累积静脉吗啡消耗量。
每组各有 38 例患者完成了研究。与对照组相比,椎旁阻滞组在术后 24 小时(差值-10.5mg,95%CI-16mg 至-6mg,P<0.001)和 48 小时(差值-12mg,95%CI-19.5mg 至-5mg,P=0.001)的累积吗啡消耗量较低。与对照组相比,椎旁阻滞组在术后 4 小时静息时的疼痛数字评分量表(NRS)评分较低(差值-2,95%CI-3 至-1,P<0.001)。与对照组相比,椎旁阻滞组在术后 12 小时主动疼痛 NRS 评分较低(差值-1,95%CI-2 至 0,P=0.005)。术后 3 个月,椎旁阻滞组的感觉迟钝(OR 0.28,95%CI 0.11-0.75,P=0.009)和麻木(OR 0.26,95%CI 0.07-0.88,P=0.024)的发生率低于对照组。
间断推注椎旁阻滞可减少阿片类药物的使用,并在开腹肝切除术后患者在住院期间和出院后均有更好的恢复。
clinicaltrials.gov(NCT04304274),日期:2020 年 3 月 11 日。